Literature DB >> 2056118

Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.

K Akashi1, T Shibuya, M Harada, Y Takamatsu, N Uike, T Eto, Y Niho.   

Abstract

We studied the effects of IL-4 on the spontaneous proliferation of chronic myelomonocytic leukemia (CMMoL) cells in vitro. IL-4 (100 U/ml) suppressed the spontaneous DNA synthesis by approximately 50% in 5 of 8 cases examined. IL-4 (100 U/ml) also inhibited the spontaneous colony formation by CMMoL cells in a methylcellulose culture by 50-97% in all of the 10 cases in which spontaneous colonies were formed. This IL-4-mediated suppression of the growth of CMMoL cells was completely abolished by the addition of anti-IL-4 neutralizing antibodies. The spontaneous CMMoL colonies were substantially suppressed by the addition of either anti-IL-6 or anti-granulocyte/macrophage colony-stimulating factor (GM-CSF) antibodies to the colony assay system: the addition of both anti-IL-6 and anti-GM-CSF antibodies resulted in greater than 80% inhibition of the colony formation by CMMoL cells. On the other hand, none of anti-IL-1-beta, anti-granulocyte-CSF, anti-macrophage-CSF, or anti-tumor necrosis factor-alpha antibodies affected the CMMoL colony formation. In the supernatants from 24-h cultures of CMMoL cells, high levels of IL-6 and GM-CSF were demonstrated in 9 of 9 and 2 of 9 cases examined, respectively. IL-4 (100 U/ml) almost completely inhibited the secretion of IL-6 and GM-CSF by CMMoL cells. These observations suggest that IL-4 suppresses the spontaneous proliferation of CMMoL cells by inhibiting their production of IL-6 and/or GM-CSF, both of which could act in vitro as an autocrine growth factor for CMMoL cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056118      PMCID: PMC296023          DOI: 10.1172/JCI115281

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Annotation: Subacute and chronic myelomonocytic leukaemia: a distinct haematological entity.

Authors:  R Zittoun
Journal:  Br J Haematol       Date:  1976-01       Impact factor: 6.998

2.  Very-low-dose cytarabine for myelodysplastic syndromes and acute myeloid leukaemia in the elderly.

Authors:  A Worsley; G J Mufti; J A Copplestone; D G Oscier; T J Hamblin
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

3.  Divergent effects of interleukin-4 (IL-4) on the granulocyte colony-stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells.

Authors:  E Vellenga; J T de Wolf; J A Beentjes; M T Esselink; J W Smit; M R Halie
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

4.  Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor.

Authors:  M Salem; R Delwel; I Touw; L A Mahmoud; E M Elbasousy; B Löwenberg
Journal:  Leukemia       Date:  1990-01       Impact factor: 11.528

5.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

6.  Treatment of myelodysplastic syndrome and atypical leukemia with low-dose aclarubicin.

Authors:  T Shibuya; T Teshima; M Harada; S Taniguchi; T Okamura; S Okamura; Y Niho
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

7.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

8.  Colony growth characteristics in chronic myelomonocytic leukemia.

Authors:  K Geissler; W Hinterberger; P Bettelheim; O Haas; K Lechner
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

Review 9.  The nature and action of granulocyte-macrophage colony stimulating factors.

Authors:  A W Burgess; D Metcalf
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

10.  Inhibition of human macrophage colony formation by interleukin 4.

Authors:  J H Jansen; G J Wientjens; W E Fibbe; R Willemze; H C Kluin-Nelemans
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

View more
  5 in total

1.  Growth factors controlling interleukin-4 action on hematopoietic progenitors.

Authors:  A Ferrajoli; T F Zipf; M Talpaz; E A Felix; Z Estrov
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

2.  Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.

Authors:  N I Obiri; J P Siegel; F Varricchio; R K Puri
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

3.  Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.

Authors:  N I Obiri; G G Hillman; G P Haas; S Sud; R K Puri
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

4.  Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).

Authors:  K N Leung; N K Mak; M C Fung; A J Hapel
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

5.  Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner.

Authors:  P Peña-Martínez; M Eriksson; R Ramakrishnan; M Chapellier; C Högberg; C Orsmark-Pietras; J Richter; A Andersson; T Fioretos; M Järås
Journal:  Leukemia       Date:  2017-08-18       Impact factor: 11.528

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.